ENDOBEAM SINGLE-USE HOLMIUM LASER FIBER
Report
- Report Number
- 1018233-2012-01943
- Event Type
- Malfunction
- Date Received
- December 3, 2012
- Report Date
- November 5, 2012
- Manufacturer
- LASER PERIPHERALS LLC
- Product Code
- GEX
- PMA / PMN Number
- K120926
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER
Narratives
SAMPLE IS FORTHCOMING. THE INVESTIGATION IS STILL IN PROGRESS. THE LOT NUMBER IS UNK; THEREFORE, THE DEVICE HISTORY RECORD COULD NOT BE REVIEWED. ONCE THE SAMPLE IS RECEIVED, A SUPPLEMENTAL MDR REPORT WILL BE FILED. THE INSTRUCTIONS FOR USE WHICH ACCOMPANIES ALL DEVICES CURRENTLY ADDRESSES POTENTIAL RISK ASSOCIATED WITH SURGICALLY IMPLANTED MATERIALS. THE INSTRUCTIONS FOR USE STATES IN THE PRECAUTIONS: WHEN REMOVING THE FIBER FROM ITS POUCH OR TRAY, SECURE THE DISTAL TIP TO AVOID DAMAGE OR CONTAMINATION. DO NOT APPLY EXCESSIVE FORCE TO THE TIP OF THE FIBER AS BREAKAGE MAY RESULT. BEGIN LASING AT THE LOWEST POSSIBLE POWER/ENERGY SETTING TO ACHIEVE THE DESIRED EFFECT. USE LOWER POWER LEVELS AND SHORTER PULSES TO FAMILIARIZE YOURSELF WITH THE OPERATION OF THE BARD ENDOBEAM HOLMIUM LASER FIBER. HIGH POWER/LONG DURATION OF LASER ENERGY WHILE PLACING THE TIP IN CONTACT WITH TISSUE MAY DAMAGE OR SIGNIFICANTLY REDUCE THE LIFE OF THIS PRODUCT. DIRECT CONTACT BY LASER BEAM MAY CAUSE DAMAGE TO GUIDEWIRES, BASKETS OR OTHER URETEROSCOPIC ACCESSORIES. IF FIBER TIP IS VISIBLY DAMAGED OR REQUIRES EXCESSIVE AMOUNTS OF ENERGY TO AFFECT COAGULATION OR VAPORIZATION, DISCONTINUE USE AND REPLACE WITH A NEW FIBER FOR OPTIMUM RESULT. IF DESIRED, STRIP AND CLEAVE THE FIBER AS OUTLINED IN THE "INSTRUCTIONS FOR STRIPPING AND CLEAVING" AND "FIBER OUTPUT TEST" SECTIONS OF THIS IFU. DO NOT EXCEED THE RECOMMENDED POWER LEVELS WHEN UTILIZING THE BARD ENDOBEAM HOLMIUM LASER FIBER. CHECK THE DEVICE FOR COMPLETENESS ONCE REMOVED FROM PT. ADVERSE EVENTS: THE POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH HOLMIUM LASER FIBERS MAY INCLUDE BUT ARE NOT LIMITED TO: PERFORATION, HEMATOMA, VASOVAGAL RESPONSE, INFECTION, THERMAL DAMAGE, EDEMA, BLEEDING, DISCOMFORT, HYPERTENSION, DELAY IN HEALING, POST-PROCEDURE FEVER AND LEUKOCYTOSIS (ASSOCIATED WITH TISSUE DESTRUCTION). (B)(4).
IT WAS REPORTED THAT THE PRODUCT SNAPPED IN HALF DURING THE PROCEDURE. DEVICE REMAINED IN THE SCOPE DURING THE BREAKAGE AND WAS REMOVED WITHOUT INCIDENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDOBEAM SINGLE-USE HOLMIUM LASER FIBER | GEX | LASER PERIPHERALS LLC | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |